Article

[Osteoporosis].

Service des maladies osseuses, Département des spécialités de médecine, HUG et Faculté de medecine, 1211 Geneve 14.
Revue médicale suisse 01/2013; 9(369):125-31.
Source: PubMed

ABSTRACT Type 2 diadetes is associated with an increased risk of fractures. Calcium supplements are still in the middle of a cardiovascular controversy. Swiss recommandations are available for vitamin D supplementation. Zoledronate exerts a long-term remaining effect on bone resorption. After 5 years treatment with denosumab, fracture incidence remains low. Atypical femoral fractures associated with bisphosphonates treatment have been evaluated in the university hospital of Geneva.

0 Followers
 · 
73 Views